/Companies

Inocras

5 known investors

Find your way into Inocras

Sign up to see every warm intro you have to Inocras

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Inocras team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Inocras is a bioinformatics company that uses whole genome sequencing and proprietary analytics to produce clinically actionable insights for patient diagnosis and treatment, operating a CLIA-certified and CAP-accredited lab. It serves patients, clinicians, and researchers with whole genome diagnostic testing, sequencing and interpretation services, genetic counseling, and clinical trial matching.

Founders & leadership

YJYoungSeok Ju
YoungSeok JuGenomics co-founder

Investors · 5

Funding

SEC filings, press & company announcements

$62M disclosed across 2 rounds · 2026

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Inocras do?
Inocras is a bioinformatics company that uses whole genome sequencing and proprietary analytics to produce clinically actionable insights for patient diagnosis and treatment, operating a CLIA-certified and CAP-accredited lab. It serves patients, clinicians, and researchers with whole genome diagnostic testing, sequencing and interpretation services, genetic counseling, and clinical trial matching.
Who founded Inocras?
Inocras was founded by YoungSeok Ju.
Who are Inocras's investors?
Inocras's investors include Dunamu & Partners, Schmidt, DSC Investment, IMM Investment, Intervest.
How much funding has Inocras raised?
Inocras has disclosed $62M raised across 2 rounds.